A new publication on GHK-Cu appeared in the journal Pharmaceutics on August 27, 2026. The paper is titled "GHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo: Coordination Chemistry, Formulation Science, Therapeutic Evidence, and a Translational Roadmap."
According to the publication record, the work addresses GHK-Cu from several angles. These include its coordination chemistry, its formulation science, and its therapeutic evidence base. The title also indicates the publication proposes a translational roadmap for the compound.
This entry reflects the publication's title and journal placement as listed in the source record. No specific findings, data points, or conclusions from the paper are included here beyond what the title itself states. Readers interested in the full scope of the coordination chemistry, formulation, or therapeutic discussion should consult the publication directly through the source link provided.
GHK-Cu remains classified as approved under current regulatory status. This publication is noted as a new addition to the literature on the compound as of its listed date. For further background on GHK-Cu, readers can consult the compound overview.